IMARC Group, a leading market research company, has recently released a report titled “Blood Culture Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global blood culture test market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
What Are The Growth Prospects Of The Blood Culture Test Industry?
According to the report, The global blood culture test market size reached US$ 4.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.
What is Blood Culture Test?
A blood culture test is a medical diagnostic procedure to identify bacterial, fungal, and mycobacterial infections. Its purpose is to detect the presence of various microorganisms in a blood sample and prevent the development of sepsis, a life-threatening condition. The test involves using blood culture media, assay kits, reagents, accessories, automated blood culture systems, and supporting laboratory equipment. At present, blood culture tests find extensive applications in determining the specific pathogens responsible for the infection and the potential ways to combat the disease across the globe.
Request for a free sample copy of this report: https://www.imarcgroup.com/blood-culture-test-market/requestsample
What are the growth prospects and trends in the Blood Culture Test industry?
The global blood culture test market is primarily driven by the rising prevalence of chronic and infectious diseases. Moreover, the increasing geriatric population, which is more susceptible to sepsis and other medical conditions, is positively influencing the market growth. Additionally, the surging use of blood culture tests by laboratories, diagnostic centers, and other healthcare institutes to detect the presence of antibodies in the blood, identify infected individuals, and prevent the spread of the disease has catalyzed market growth. Furthermore, the escalating demand for blood culture tests amid the sudden outbreak of the coronavirus (COVID-19) pandemic to analyze specimens is contributing to the market growth. Other factors, including extensive research and development (RD) activities in the medical sciences, rising health awareness among the masses, and improvements in healthcare infrastructure, are also anticipated to drive the market further.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbott Laboratories (ABT)
- Beckman Coulter ( BEC )
- BD (Becton, Dickinson and Company) (NYSE:BDX)
- BIOMERIEUX (BIM.PA)
- Bruker Corporation (BRKR)
- Cepheid (NASDAQ:CPHD). (Danaher Corporation)
- Luminex Corporation
- Merck Group
- Siemens Healthineers AG
- Roche Diagnostics
- T2 Biosystems, Inc. (TTOO)
- Thermo Fisher Scientific Inc. (NYSE: TMO)
Ask Analyst for Free Sample Report: https://www.imarcgroup.com/request?type=reportid=2275flag=F
The report has segmented the market on the basis of Product Type, End-User and Region.
Breakup by Testing Method:
Breakup by Product:
- Blood Culture Media
- Aerobic Blood Culture Media
- Anaerobic Blood Culture Media
- Fungi/Yeast Blood Culture Media
- Mycobacteria Blood Culture Media
- Assay Kits and Reagents
- Blood Culture Accessories
- Blood Culture Media
- Automated Blood Culture Systems
- Supporting Laboratory Equipment
- Colony Counters
- Gram Stainers
- Software and Services
Breakup by Technology:
- Culture-based Technology
- Molecular Technology
- Proteomic Technology
Breakup by Application:
- Bacterial Infection
- Fungal Infection
- Mycobacterial Infection
Breakup by End-User:
- Hospital Laboratories
- Reference Laboratories
- Research Laboratories
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal